• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Characterization of the SARS-CoV-2 genomes in Egypt in first and second waves of infection

tetano

Editor, Senior Moderator
Sci Rep


. 2021 Nov 3;11(1):21632.
doi: 10.1038/s41598-021-99014-4.
Characterization of the SARS-CoV-2 genomes in Egypt in first and second waves of infection


Abdel-Rahman N Zekri[SUP] 1 [/SUP], Abeer A Bahnasy[SUP] 2 [/SUP], Mohamed M Hafez[SUP] 3 [/SUP], Zeinab K Hassan[SUP] 3 [/SUP], Ola S Ahmed[SUP] 3 [/SUP], Hany K Soliman[SUP] 3 [/SUP], Enas R El-Sisi[SUP] 3 [/SUP], Mona H Salah El Dine[SUP] 4 [/SUP], May S Solimane[SUP] 4 [/SUP], Lamyaa S Abdel Latife[SUP] 4 [/SUP], Mohamed G Seadawy[SUP] 5 [/SUP], Ahmed S Elsafty[SUP] 5 [/SUP], Mohamed Abouelhoda[SUP] 6 [/SUP]



Affiliations

Abstract

At Wuhan, in December 2019, the SRAS-CoV-2 outbreak was detected and it has been the pandemic worldwide. This study aims to investigate the mutations in sequence of the SARS-CoV-2 genome and characterize the mutation patterns in Egyptian COVID-19 patients during different waves of infection. The samples were collected from 250 COVID-19 patients and the whole genome sequencing was conducted using Next Generation Sequencing. The viral sequence analysis showed 1115 different genome from all Egyptian samples in the second wave mutations including 613 missense mutations, 431 synonymous mutations, 25 upstream gene mutations, 24 downstream gene mutations, 10 frame-shift deletions, and 6 stop gained mutation. The Egyptian genomic strains sequenced in second wave of infection are different to that of the first wave. We observe a shift of lineage prevalence from the strain B.1 to B.1.1.1. Only one case was of the new English B.1.1.7. Few samples have one or two mutations of interest from the Brazil and South Africa isolates. New clade 20B appear by March 2020 and 20D appear by May 2020 till January 2021.
 
Back
Top Bottom